Alector (ALEC) EBT Margin (2018 - 2026)
Alector's (ALEC) quarterly EBT Margin came in at 688.55% in Q2 2026, down 30090.0% year-over-year from N/an in Q2 2025, and up 68.59% quarter-over-quarter from 2192.16% in Q1 2026.
Analysis
Alector (ALEC) EBT Margin (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported EBT Margin for 9 consecutive years, with 688.55% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin fell 30090.0% year-over-year to 688.55% in Q2 2026; TTM through Jun 2026 was 847.98%, a 70594.0% decrease from a year earlier, with the FY2025 full-year figure at 678.36%, down 56010.0% from the prior year.
- EBT Margin was 688.55% for Q2 2026 at Alector, up from 2192.16% in the prior quarter.
- Over five years, EBT Margin peaked at 13.68% in Q2 2022 and troughed at 2192.16% in Q1 2026.
- A 5-year average of 479.02% and a median of 290.49% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin soared 109016 bps in 2022 and slumped 109061 bps in 2026, its largest moves.
- Over 5 years, EBT Margin stood at 358.08% in 2022, then increased by 27 bps to 261.8% in 2023, then surged by 99 bps to 3.74% in 2024, then plunged by 15825 bps to 594.82% in 2025, then dropped by 16 bps to 688.55% in 2026.
- The last three EBT Margin figures came in at 688.55% (Q2 2026), 2192.16% (Q1 2026), and 594.82% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 27.53% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -131.41% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 41.75% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 35.61% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 35.78% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -528.97% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 13.77% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 4.84% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -2.67% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -688.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -688.55% |
| Mar 31, 2026 | -2,192.16% |
| Dec 31, 2025 | -594.82% |
| Sep 30, 2025 | -1,063.40% |
| Jun 30, 2025 | -387.66% |
| Mar 31, 2025 | -1,101.55% |
| Dec 31, 2024 | -3.74% |
| Sep 30, 2024 | -275.19% |
| Jun 30, 2024 | -255.94% |
| Mar 31, 2024 | -226.97% |
| Dec 31, 2023 | -261.80% |
| Sep 30, 2023 | -474.51% |
| Jun 30, 2023 | 4.92% |
| Mar 31, 2023 | -271.65% |
| Dec 31, 2022 | -358.08% |
| Sep 30, 2022 | -305.78% |
| Jun 30, 2022 | 13.68% |
| Mar 31, 2022 | -179.21% |
| Dec 31, 2021 | -397.37% |
| Sep 30, 2021 | 69.40% |